Exchange: NASDAQ·Updated 07:33 PM EDT
NMRA logo

NMRA Neumora Therapeutics Inc.

$0.7349
$0.02
(2.67%)
Today
Closed $0.73
$0.0049
(0.67%)
After Hours
EarningsNov 5
Mkt Cap$137.16M
Vol3.88M

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. The firm offers a precision medicine approach for brain diseases through the integration of data science and neuroscience. It focuses on advancing medicines for therapeutically relevant targets implicated in CNS diseases, targeting novel mechanisms of action with best-in-class pharmacology. The company was founded by Paul L. Berns, Carol Suh and Mike Poole in November 2019 and is headquartered in Watertown, MA.
67

Bullish Sentiment

How do you feel about NMRA?

Advertisement|Remove ads.